2025年2月26日 · Grifols is a leading global healthcare company. Our trusted and innovative plasma-derived medicines, other biopharmaceuticals and solutions in transfusion medicine …

Grifols is a global healthcare company that since 1909 has enhanced the health and well-being of people around the world. A leader in essential plasma-derived medicines and transfusion …

At Grifols, we are pioneers in the development of therapies derived from blood and plasma. We contribute to building the future of healthcare to improve people's well-being. Since 1909, we …

Grifols es una compañía global líder en el sector de la salud. Nuestros innovadores medicamentos derivados del plasma, otros productos biofarmacéuticos y soluciones en …

Grifols USA was established in 2003. Based in Los Angeles, we cover the U.S. market where we offer a comprehensive portfolio of Grifols products and services. The company is one of the …

An experienced and trusted partner to blood banks and hospital transfusion centers, Grifols is a global leader in transfusion medicine and a pioneer in disease detection. Learn how our …

Grifols treatments center on immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. Each area features therapies helping patients …

Grifols Brazil was established in 1998. Based in Curitiba, Parana, and with a commercial office in Sao Paulo, we cover the Brazilian market. We offer a comprehensive portfolio of Grifols …

Grifols Deutschland wurde 1997 gegründet. Von Frankfurt aus leiten wir den Biopharma-Vertrieb in Deutschland und den Diagnostic-Vertrieb in den Märkten Deutschland, Österreich und …

Following the recent Capital Markets Day on 27 Feb 2025, Grifols announces it will hold a Non-Deal Roadshow (NDR) for equity investors during the week of March 17th, 2025. The NDR will …